|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
La Merie, Aug 2008, Pages: 90
The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small molecules, proteins, DNA, RNA and vaccines targeting the toll-like receptors TLR3, TLR4, TLR5, TLR7, TLR8 and TLR9 for treatment of cancer, infectious diseases, sepsis and allergy. The analysis details molecules targeting one or more of the toll-like receptors and includes agonists, antagonists as well as vaccines and vaccine adjuvants. TLR Agonists as well as TLR Antagonists are presented sorted by receptor subtype and by therapeutic area. A list of TLR Adjuvants used in marketed vaccines and in vaccines under development is provided. TLR-adjuvanted vaccines are compiled sorted by TLR receptor subtype and by therapeutic area as prophylactic and therapeutic vaccines. The corporate R&D portfolios (more than one project) for TLR Agonists, Antagonists, Adjuvants and TLR-Adjuvanted Vaccines contained in this Competitor Analysis.
The report includes a compilation of current active projects in research and development of TLR agonists, antagonists, adjuvants and vaccines. Competitor projects are listed in a tabular format providing Information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Therapeutic Area,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Customers who bought this item also bought
Competitor Analysis: Muscarinic Receptor Agonists & Antagonists
Competitor Analysis: Psoriasis
Competitor Analysis: Thrombolytic Agents
Competitor Analysis: Obesity & Diabetes
Competitor Analysis: Obesity
Competitor Analysis: Antihypertensives
Dansk Olie Og Naturgas A/S Oil and Gas Assets Report
Citation Oil & Gas Corp. Oil and Gas Assets Report
|
|
|
|
